01—Abstract
Summary
Summary of the 8-K filed July 26, 2024. Cited figures are marked; the original filing is the authoritative source.
Rivian Automotive, Inc. filed this Current Report on Form 8-K under Item 5.02 to disclose the resignation of Dr. Kjell Gruner, its Chief Commercial Officer and President, Business Growth.
Dr. Gruner notified the company on July 24, 2024 of his decision to resign to pursue other opportunities. His last day in the Chief Commercial Officer and President, Business Growth role is July 26, 2024, but he will remain employed by the company until February 17, 2025 to assist with the transition as needed. The filing states that his resignation is not the result of any disagreement with the company on matters relating to its business, policies, or practices.
The company stated that Dagan Mishoulam, described as having played an integral role at the company for the past several years, is assuming the role of Senior Vice President, Commercial, along with many of the responsibilities previously held by Dr. Gruner. For investors, the filing is a leadership transition in the commercial function rather than a financial disclosure, and it contains no financial results or guidance.
02—Key points
Key Highlights
- Dr. Kjell Gruner, Chief Commercial Officer and President, Business Growth, resigned to pursue other opportunities, with notice given on July 24, 2024.
- Gruner's last day in his role is July 26, 2024, and he remains employed through February 17, 2025 to assist with the transition as needed.
- Dagan Mishoulam is assuming the role of Senior Vice President, Commercial, and many of Gruner's former responsibilities.
- The filing states the resignation is not due to any disagreement with the company on its business, policies, or practices.
- The filing contains no financial results, guidance, or financial figures.
03—Questions
Frequently Asked Questions
Why did Kjell Gruner resign?
The filing states that Dr. Gruner resigned to pursue other opportunities and that the resignation is not the result of any disagreement with the company on matters related to its business, policies, or practices.
Who is taking over Gruner's responsibilities?
Dagan Mishoulam is assuming the role of Senior Vice President, Commercial, along with many of the responsibilities previously held by Dr. Gruner. The filing describes him as having played an integral role at the company for the past several years.
Is Gruner leaving the company immediately?
No. Although his last day as Chief Commercial Officer and President, Business Growth is July 26, 2024, he will remain employed by the company until February 17, 2025 to assist with the transition, as needed.
Does this filing include financial results or guidance?
No. The filing consists of an Item 5.02 disclosure about an executive departure and role assignment and does not include financial results, guidance, or financial figures.
04—Continue